Lara Pillay

North America Legal Chronicle. July 6, 2026

Chiesi to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal

By Leila Ahmed

Ropes & Gray has advised Chiesi Farmaceutici S.p.A. Kirkland & Ellis and Fenwick & West have advised KalVista Pharmaceuticals, Inc. Chiesi Farmaceutici S.p.A., an international biopharmaceutical...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

North America Legal Chronicle. July 1, 2026

Zymeworks to Acquire Theravance Biopharma in $929 Million Transaction

By Laura Testa

Skadden has advised Theravance Biopharma. Kirkland & Ellis and Matheson have advised Zymeworks. Theravance Biopharma, Inc. and Zymeworks Inc. have entered into a definitive agreement under...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

North America Legal Chronicle. December 22, 2025

BioMarin to Acquire Amicus Therapeutics for $4.8 Billion

By Leila Ahmed

Jones Day has advised BioMarin Pharmaceutical Inc. in the acquisition of Amicus Therapeutics. Kirkland & Ellis has advised Amicus Therapeutics. BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) has...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

North America Legal Chronicle. November 7, 2025

Novartis Acquires Avidity Biosciences in USD 12 Billion Transaction and Completes USD 11 Billion Financing

By Leila Ahmed

Covington and Homburger have advised Novartis. Kirkland & Ellis and Wilson Sonsini Goodrich & Rosati have advised Avidity Biosciences. Linklaters has advised a global underwriting syndicate....

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Beep Closes its Series B Funding to Expand Autonomous Mobility Solutions

Alif Semiconductor to Be Acquired by Analog Devices in US$1.35 Billion Deal

TwoStep Therapeutics Secures US$62.5 Million Series A Financing and IND Clearance for TS-104

YPF Issues USD 1.2 Billion Notes and Completes Cash Tender Offers

Pluma Agroavícola Participates in BRL 160 Million Agribusiness Financing through FIDC and FIAGRO Structures

Mirgor’s Issuance of Additional Class VI and Class VII Notes

The Exploration Company Raises $450 Million in Series C Financing for Space Expansion

PKO Bank Polski Issues €500 Million Senior Non-Preferred Green Notes

Orgvue Acquired by Main Capital Partners

Solar Group Proposes ZAR21.8 Billion Acquisition of Omnia Holdings

Al Baraka Bank Egypt Launches Share Swap Offer for AT Lease

Genser Energy Secures EUR456 Million Syndicated Facilities for West African Expansion

Development Bank of Kazakhstan Completes Landmark RMB 3.7 Billion Dim Sum Bond Offering

E Point Zero Acquires Azura Power Holdings Limited

$100 Million Trade Finance Facility Agreement Reached Between BADEA and The Gambia Government

Copenhagen Infrastructure Partners Acquires and Secures Project Financing for Gawara Baya Hybrid Project

RBL Bank Establishes US$1bn Euro Medium Term Note Programme and Completes Inaugural US$350m Issuance

Bharat Forge Completes ?2,000 Crore Qualified Institutions Placement

Pachulski Stang Ziehl & Jones Elects Bradford Sandler as the Firm’s First Chair

Lowenstein Sandler Names Marie T. DeFalco and Sara R. Werner Co-chairs of Venture Funds Launch Group

Finn Dixon & Herling Names Claire Stevens as Chair of Investment Management Practice

Mayer Brown expands premier finance platform with addition of leveraged finance and private credit partner Kerrick Seay in New York

O’Melveny Expands Bankruptcy & Restructuring Team with Leading Corporate Restructuring Lawyer Penelope Jensen

Milbank Strengthens Tax Practice with the Addition of Leading Tax Lawyer Alex Anderson

Chiesi to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal

Membership Required

Zymeworks to Acquire Theravance Biopharma in $929 Million Transaction

Membership Required

BioMarin to Acquire Amicus Therapeutics for $4.8 Billion

Membership Required

Novartis Acquires Avidity Biosciences in USD 12 Billion Transaction and Completes USD 11 Billion Financing

Membership Required